Skip to main content

Funding

09
Feb 2024

New national catalog for genetic tests released in Spain

On January 23, 2024, the Ministry of Health introduced a new national catalog, which guarantees the Spanish population's genetic tests nationwide. Currently, the catalog includes 672 tests in eight disease areas, including adult and pediatric oncohematology, pharmacogenomics, hereditary metabolic and mitochondrial diseases, and others. Twelve more disease areas are expected to be added in 2024.
27
Dec 2023

Funding of 500 million DKK for home treatment with digital solutions in Denmark

In December 2023, the Government, Danish Regions, and Municipalities (KL) signed an agreement providing 500 million DKK from 2023 to 2028 to promote the spread of digital treatment services. This will include technologies for home monitoring and targeted control for patients with chronic diseases (such as diabetes, COPD, and heart failure), thus reducing the number of physical check-ups and preventing unnecessary hospitalizations.
21
Dec 2023

Updates in the coverage of medical services in Switzerland in 2024

On November 29, 2023, the Swiss Federal Office of Public Health published the changes that will occur to the Services Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The updates will enter into force on January 1 or July 1, 2024, and they relate to the list of explicitly evaluated services (Annex 1 of KLV/OPre), outpatient-before-hospital services (Annex 1a), List of Tools and Equipment (Annex 2), and List of Analyses (Annex 3).
29
Nov 2023

Funding for AI Life Sciences Accelerator Mission in the UK

In late October 2023, the UK Government announced £100 million funding for the “AI Life Sciences Accelerator Mission”. The Mission will advance and expand the use of AI in life sciences and tackle the country’s major health challenges outlined by Life Sciences Vision.
27
Nov 2023

Reduction of reimbursement for the clinical laboratory by 15% in Belgium

In November 2023, the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) announced the budget reduction for reimbursement of clinical laboratory services by 15% from January 2024. INAMI-RIZIV considers this reimbursement still sufficient and will reallocate released funds to other projects in health care. The reduction will not impact molecular biological and genetic testing.
24
Nov 2023

Launch of the nationwide telemedicine solution for COPD in Denmark

In November 2023, the Danish Regions announced the launch of a national telemedicine solution for patients with severe chronic obstructive pulmonary disease (COPD). The telemedicine platform Telma, developed by regions and municipalities, comprises a software application for patients connected to devices measuring patients' clinical parameters (such as blood oxygen), which clinicians then assess remotely.
23
Nov 2023

36 cardiovascular projects funded in Spain

In November 2023, the Agency for Health Quality and Assessment of Catalonia (AQuAS) informed that the La Marató Foundation selected 36 cardiovascular projects together with eight other projects in a ranked reservation list to be funded.
03
Nov 2023

€130 million allocated to launch of the Personalized Digital Care Plan in Spain

On October 20, 2023, the Spanish Ministry of Health announced that a budget of 130 million euros was allocated to support the upcoming launch of the Personalized Digital Care Plan. Healthcare digitalization is already a well-established reality that materialized into the Digital Health Strategy with more than 800 million euros budget allocated since 2021 after the COVID-19 pandemic.
11
Oct 2023

UK Government will invest £30 million in innovative technology for NHS

UK patients will benefit from a £30 million government investment in innovative medical technology, which will help ease pressures on the NHS this winter. The Integrated care systems will be able to invest in the latest technology that can help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients.
02
Oct 2023

Call for input regarding MRgFUS for the “New Methods” framework in Norway

The “New Methods” framework invited interested parties to submit information regarding magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) for treating intracranial tumors, neurodegenerative disease, and pain related to bone metastases before October 31, 2023. Ordering Forum will then decide whether the method will undergo evaluation at the national level.